BTK is not reported to have genetic evidence linking it with the autoimmune disorders being clinically tested with BTK inhibitors, but functional signaling pathways associated with clinical pathology have individual proteins that themselves interact with signaling pathways connecting to BTK (Table 3). This evidence concerns the gene BTK and autoimmune disease.